C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,065 | -51.4% | 161,863 | -28.1% | 0.00% | – |
| Q2 2023 | $619,278 | -26.4% | 225,192 | -16.0% | 0.00% | – |
| Q1 2023 | $841,730 | +312.8% | 268,067 | +675.6% | 0.00% | – |
| Q4 2022 | $203,910 | -58.0% | 34,561 | -37.6% | 0.00% | – |
| Q3 2022 | $486,000 | +133.7% | 55,370 | +100.6% | 0.00% | – |
| Q2 2022 | $208,000 | -91.9% | 27,600 | -74.0% | 0.00% | – |
| Q1 2022 | $2,572,000 | -23.2% | 106,020 | +1.9% | 0.00% | – |
| Q4 2021 | $3,350,000 | -46.4% | 104,058 | -25.6% | 0.00% | -100.0% |
| Q3 2021 | $6,252,000 | +215.1% | 139,915 | +166.9% | 0.00% | – |
| Q2 2021 | $1,984,000 | +755.2% | 52,427 | +735.9% | 0.00% | – |
| Q1 2021 | $232,000 | – | 6,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |